Clinical Trial Detail

NCT ID NCT02166905
Title DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements no
Sponsors Roswell Park Cancer Institute
Indications

ovarian carcinoma

fallopian tube carcinoma

peritoneal carcinoma

Therapies

Poly ICLC

DEC-205-NY-ESO-1 fusion protein vaccine

Epacadostat

Age Groups: adult

No variant requirements are available.